This dosing strategy may be useful in patients intolerant to once-daily statin dosing, although such an approach has not been documented ... low-density lipoprotein cholesterol (LDL-C) and ...
Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...